Dari rioH oHealth th Corp. orp. Per erso sonal nalized H ed - PowerPoint PPT Presentation

Dari rioH oHealth th Corp. orp. Per erso sonal nalized H ed Heal ealth h Management anagement NASD SDAQ: D DRI RIO

Forw orward rd Look ooking S g Sta tate tements This presentation of DarioHealth Corp. (the “Company”) and statements of our management or agents related thereto contain or may contain forward-looking • statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”). Statements which are not historical reflect our current expectations and projections about our future results, performance, liquidity, financial condition, prospects and opportunities and are based upon information currently available to us and our management and their interpretation of what is believed to be significant factors affecting our business, including many assumptions regarding future events. Words such as “seek,” “intend,” “believe,” “plan,” “estimate,” “expect,” “anticipate,” “will,” “would,” and other similar expressions all denote forward-looking statements within the meaning of the Act. Readers are cautioned that actual results, performance, liquidity, financial condition and results of operations, prospects and opportunities could differ materially and • perhaps substantially from those expressed in, or implied by, these forward-looking statements as a result of various risks, uncertainties and other factors. Factors that could cause or contribute to such differences include, but are not limited to our compliance with regulatory requirements, the impact of current and any future competition, our current and future capital requirements and our ability to satisfy our capital needs through financing transactions or otherwise, our ability to manufacture, market and generate sales of our Dario™ diabetes management solution, as well as other factors and risks discussed in the Company’s filings (including the results of the company’s commercial and regulatory plans for Dario™) with the U.S. Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. In addition, readers are cautioned that any estimates, forecasts or projections contained in this presentation or as may be discussed by our management or agents • have been prepared by our management in good faith on a basis believed to be reasonable. However, such estimates, forecasts and projections involve significant elements of subjective judgment and analysis and no representation can be made as to their attainability. No representation or warranty (express or implied) is made or is to be relied upon as a promise or representation as to our future performance. Readers are cautioned that such estimates, forecasts or projections have not been audited and have not been prepared in conformance with generally accepted accounting principles. 2 NASDAQ: DRIO

Dar ario ioHealt ealth | h | Inv nves estment ent Hig Highlig hlight hts • Scalable diabetes management platform • Large and growing global market opportunity • Regulatory clearance achieved in several countries • Multiple growth drivers • Experienced management team • Strong revenue growth 3 NASDAQ: DRIO

Dar ario ioHealt ealth | h | At a G a Glance lance DarioHealth Corp. (NASDAQ: DRIO) is a leading global digital health company with 2011 personalized, mobile health solutions. We believe in empowering people with chronic Founded conditions, with more control and independence to manage their daily challenges and changes. Harnessing the power big data, we’re able to give each person unparalleled, real-time insights New York and the guidance they need to navigate their unique journey. Headquartered 40 Qua uarter terly R Rev evenue enue Employees $1,375 $1,400 7 $1,210 Countries with users $1,200 $1,007 4 $1,000 $838 Regulatory bodies approvals (in thousands) $800 $728 $669 5 $568 $600 Countries fully reimbursed $400 $308 $273 ~$5m $175 $200 $67 2017 Revenue $0 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Q4 2016 Q1 2017 Q2 2017 Q3 2017 4 NASDAQ: DRIO

Dar ario ioHealt ealth | h | Geo eograp aphical M hical Mar arket et Over erview iew Dario currently has access to 425m 48.5 million people with diabetes worldwide People with diabetes (2017) 693m People with diabetes projected by 2045 471m Pre-diabetes projected by 2035* * Pred Prediabet etes diagno nosis and nd t trea reatment ment: : A rev review ew, , by by Nihdi di Bans nsal, , 15 15 Ma Mar 2015 2015 UK UK Austr tralia lia Can anad ada a Ita taly ly USA SA Netherlan ands German any Since Q1 2015 Since Q3 2015 Since Q4 2015 Since Q1 2016 Since Q2 2016 Since Q3 2016 Since Q3 2017 Insurance Coverage Insurance Coverage Insurance Coverage Insurance Coverage Partial Coverage Insurance Coverage 1.1m 2.6m 3.4m 30.2m 1.0m 7.5m 2.7m Population with Diabetes by Country 5 NASDAQ: DRIO

Dar ario ioHealt ealth | h | Diab iabet etes es Monit nitoring ng Shift hifting ing to a Fo a Focus cus on P n Per ersonali nalizat ation Traditional Approach Dario Health Periodic data • Longitudinal data • General statistics based treatment • Personalized precision treatment • Independent factors - silo events • Dynamic impact of each factor • Driven by independent professionals & • Driven by personalized data & AI/ML • theories technology 6 NASDAQ: DRIO

Dar ario ioHealt ealth | h | Proven R en Red educt uctio ion in n in Healt Healthcar hcare Costs* Diabetes Related Health Costs Dario Savings A person with diabetes with complications can cost as much as $20,700 annually Studies tudies ha have s e sho hown tha n that t Dario io’s 1% % reductio eduction n in H in HbA bA1c y c yields ields s subs ubsta tantia ntial l sav avings gs Total annua nnual a avera erage e Total annua nnual a avera erage e $80 80 - $100 100 per per pa patient tient per per m month. nth. med edica cal co costs diabet etes es-speci ecific co c costs $11, 11,000 000 - $13, 13,700 700 $7, 7,900 900 $35. 35.8 8 billio billion n of po f potentia tential l saving ings to to the the U.S. hea healthca lthcare e system tem. * American Diabetes Association (ADA), The Cost of Diabetes, Last reviewed Oct 2013, http://www.diabetes.org/advocacy/news-events/cost-of-diabetes.html, (Accessed Nov 2017). 7

Dar ario ioHealt ealth | h | Dar ario io’s Manag anaged ed C Car are e Solut lutio ion Device & App Data and performance driven Targeted coaching approach • 100% real-time data capture • Cloud storage of all data • Enable scalable coaching capabilities • Statistics snapshot and dashboard • Automated data driven guidance • Simple integration with clinical programs • Personalized logbook & tracking • Clear ROI driven • Collaboration with professional coaching • User-controlled sharing with healthcare – Lower coast • Personalized digital guidance – Clinical outcomes 8

Dar ario ioHealt ealth | | The D The Dar ario io Eng ngag age e Plat latfo form Monitoring Coaching 100% data capture, Personalized real-time data health guidance sync to secure Dario Engage Platform provides full coverage, scalable cloud storage healthcare solutions that are easily customized to integrate with any clinical programs covering all facets of diabetes management and care: Type1, Type2, gestational diabetes, and prediabetes. Personalized platform, Clinical program mobile application, integration, coaching, automated digital guiding, processes, and community, reporting support Management Engagement 9

Dar ario ioHealt ealth | h | Compet etit itive Land Landscap cape Monitoring Coaching BT Sync Dedicated Offline DarioHealth is the only comprehensive diabetes management platform Management Engagement 10

Dar ario ioHealt ealth | h | Grow rowth th Stra Strate tegy O gy Ove vervi view Other digital services Dario Engage services Market Reach Monetize Support The Data Other Over the Expand Current offering Disease Long-Term Into States Enter the Additional Employer Market Upsell Countries & Health Partners Products & Continue to Add Services Members Near-Term Long-Term 2017 2018 2019 and beyond 11 NASDAQ: DRIO